SCHEMBL29395436

SCHEMBL29395436

CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)[C@@H](OC(=O)CC)C[C@@]21C

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 7/20 0.84
▸ PGR P06401 5/20 0.84
▸ ADORA3 P0DMS8 2/20 0.84
▸ NR1I2 O75469 2/20 0.84
▸ MAPT P10636 2/20 0.84
▸ DRD2 P14416 1/20 0.84
▸ OPRD1 P41143 1/20 0.84
▸ USP2 O75604 7/20 0.72
▸ CYP3A4 P08684 6/20 0.72
▸ HIF1A Q16665 2/20 0.72
▸ AR P10275 1/20 0.72
▸ CHRM1 P11229 1/20 0.72
▸ CNR1 P21554 1/20 0.72
▸ TBXA2R P21731 1/20 0.72
▸ LMNA P02545 3/20 0.70
▸ CYP2C9 P11712 2/20 0.70
▸ MLNR O43193 1/20 0.70
▸ ABCB11 O95342 1/20 0.70
▸ CYP3A5 P20815 1/20 0.70
▸ PPARG P37231 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL509817 1.00 NR3C1 (0.84) NR3C1PGRADORA3NR1I2MAPT
SCHEMBL11748332 1.00 NR3C1 (0.84) NR3C1PGRADORA3NR1I2MAPT
SCHEMBL4174889 0.96 NR3C1 (0.77) NR3C1PGRADORA3NR1I2MAPT
SCHEMBL1530974 0.95 NR3C1 (0.80) NR3C1PGRADORA3NR1I2MAPT
SCHEMBL7593 0.95 NR3C1 (0.82) NR3C1PGRADORA3NR1I2MAPT
Butyric Acid SCHEMBL4899027 0.95 NR3C1 (0.76) NR3C1PGRADORA3NR1I2MAPT
SCHEMBL7271 0.95 NR3C1 (0.78) NR3C1PGRADORA3NR1I2MAPT
SCHEMBL20485505 0.95 NR3C1 (0.78) NR3C1PGRADORA3NR1I2MAPT
SCHEMBL11749891 0.95 NR3C1 (0.76) NR3C1PGRADORA3NR1I2MAPT
Betamethasone Dipropionate SCHEMBL15876389 0.94 NR3C1 (0.88) NR3C1PGRADORA3NR1I2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230277452-A1 COMPOSITIONS, DEVICES AND METHODS FOR TREATING NASAL, OTIC AND OTHER TISSUE INFECTION AND/OR INFLAMMATION OTICARA, INC. (US) 2023-09-07 — — US disclosed
CN-116600785-A Compositions, devices and methods for treating infection and/or inflammation of the nose, ear and other tissues 奥蒂卡拉股份有限公司 2023-08-15 — — CN disclosed
EP-4203958-A1 COMPOSITIONS DEVICES AND METHODS FOR TREATING NASAL, OTIC AND OTHER TISSUE INFECTION AND/OR INFLAMMATION Oticara, Inc. (US) 2023-07-05 — — EP disclosed
WO-2022047042-A1 COMPOSITIONS DEVICES AND METHODS FOR TREATING NASAL, OTIC AND OTHER TISSUE INFECTION AND/OR INFLAMMATION OTICARA, INC. (US) 2022-03-03 — — WO disclosed
Send feedback